Harvard Management Company

Latest statistics and disclosures from Harvard Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Harvard Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Harvard Management

Companies in the Harvard Management portfolio as of the March 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Royalty Pharma Shs Class A (RPRX) 26.1 $467M -27% 11M 43.62
Intercontinental Exchange (ICE) 12.9 $230M NEW 2.1M 111.68
Adobe Systems Incorporated (ADBE) 8.7 $155M NEW 326k 475.37
Abcellera Biologics (ABCL) 7.8 $139M 4.1M 33.96
Facebook Cl A (FB) 6.7 $121M 410k 294.53
Palo Alto Networks (PANW) 6.1 $110M +103% 341k 322.06
Scientific Games (SGMS) 5.8 $103M 2.7M 38.52
Microsoft Corporation (MSFT) 3.4 $62M -68% 262k 235.77
salesforce (CRM) 1.9 $35M -82% 165k 211.87
Invesco Qqq Tr Unit Ser 1 (QQQ) 1.9 $34M -4% 108k 319.13
Purecycle Technologies 1.8 $33M NEW 1.3M 25.50
Revolution Medicines (RVMD) 1.7 $31M 670k 45.88
Ishares Tr Core S&p500 Etf (IVV) 1.5 $26M 66k 397.83
Praxis Precision Medicines I (PRAX) 1.4 $26M 779k 32.76

Setup an alert

Harvard Management Company will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Pliant Therapeutics (PLRX) 1.2 $22M 562k 39.33
Relay Therapeutics (RLAY) 1.0 $19M 541k 34.57
Unity Software (U) 1.0 $19M NEW 186k 100.31
10x Genomics Cl A Com (TXG) 0.9 $16M NEW 90k 181.00
Sana Biotechnology 0.9 $16M NEW 469k 33.47
Kinnate Biopharma (KNTE) 0.9 $16M 498k 31.16
Spdr Gold Tr Gold Shs (GLD) 0.9 $16M 97k 159.96
Generation Bio (GBIO) 0.8 $15M 512k 28.46
Roblox Corp Cl A 0.7 $13M NEW 198k 64.83
Nurix Therapeutics (NRIX) 0.5 $9.8M 315k 31.09
Vanguard Tax-managed Intl Ftse Dev Mkt Etf (VEA) 0.5 $8.6M 176k 49.11
Pinduoduo Sponsored Ads (PDD) 0.3 $5.7M NEW 43k 133.89
Ishares Tr Core S&p Scp Etf (IJR) 0.3 $5.5M 50k 108.52
Nucana Sponsored Adr (NCNA) 0.3 $5.0M -40% 992k 4.99
Fulcrum Therapeutics (FULC) 0.3 $4.8M 411k 11.78
Ishares Tr Core S&p Mcp Etf (IJH) 0.2 $4.2M 16k 260.28
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO) 0.2 $4.2M 81k 52.05
Fs Development Corp Ii Com Cl A 0.2 $4.0M NEW 400k 9.96
Magenta Therapeutics (MGTA) 0.2 $3.9M 333k 11.84
Decibel Therapeutics 0.2 $3.7M NEW 329k 11.36
Gemini Therapeutics 0.2 $3.4M NEW 250k 13.55
Seres Therapeutics (MCRB) 0.2 $2.7M 132k 20.59
Dyne Therapeutics (DYN) 0.1 $1.7M 107k 15.53
Dada Nexus Ads (DADA) 0.1 $1.4M NEW 50k 27.14

Past Filings by Harvard Management

SEC 13F filings are viewable for Harvard Management going back to 2010

View all past filings